Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene in 13q12.2 are among the most common driver events in acute leukemia, leading to increased cell proliferation and survival through activation of the phosphatidylinositol 3-kinase/AKT-, RAS/MAPK-, and STAT5-signaling pathways. In this study, we examine the pathogenetic impact of somatic hemizygous 13q12.2 microdeletions in B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) using 5 different patient cohorts (in total including 1418 cases). The 13q12.2 deletions occur immediately 5' of FLT3 and involve the PAN3 locus. By detailed analysis of the 13q12.2 segment, we show that the deletions lead to loss of a topologically associating domain border and an enhancer of FLT3. This results in increased cis interactions between the FLT3 promoter and another enhancer located distally to the deletion breakpoints, with subsequent allele-specific upregulation of FLT3 expression, expected to lead to ligand-independent activation of the receptor and downstream signaling. The 13q12.2 deletions are highly enriched in the high-hyperdiploid BCP ALL subtype (frequency 3.9% vs 0.5% in other BCP ALL) and in cases that subsequently relapsed. Taken together, our study describes a novel mechanism of FLT3 involvement in leukemogenesis by upregulation via chromatin remodeling and enhancer hijacking. These data further emphasize the role of FLT3 as a driver gene in BCP ALL.

Childhood Leukaemia Investigation Prague Prague Czech Republic

Department of Clinical and Experimental Medicine Linköping University Linköping Sweden

Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine Charles University University Hospital Motol Prague Czech Republic; and

Division of Clinical Genetics Department of Laboratory Medicine Lund University Lund Sweden

Division of Laboratory Medicine Department of Clinical Genetics and Pathology Skåne University Hospital Lund Sweden

Division of Molecular Hematology Lund Stem Cell Center Department of Laboratory Medicine Lund University Lund Sweden

Laboratory of Hematology Centre Hospitalier Universitaire Lille Lille France

Unité Mixte de Recherche en Santé 1172 INSERM University of Lille Lille France

Blood. 2020 Aug 20;136(8):919-920. doi: 10.1182/blood.2020006607. PubMed

Blood Adv. 2021 Apr 27;5(8):2075-2078. doi: 10.1182/bloodadvances.2020003643. PubMed

Zobrazit více v PubMed

Annesley CE, Brown P. The biology and targeting of FLT3 in pediatric leukemia. Front Oncol. 2014;4:263. PubMed PMC

Armstrong SA, Mabon ME, Silverman LB, et al. . FLT3 mutations in childhood acute lymphoblastic leukemia. Blood. 2004;103(9):3544-3546. PubMed

Yang M, Vesterlund M, Siavelis I, et al. . Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia. Nat Commun. 2019;10(1):1519. PubMed PMC

Paulsson K, Lilljebjörn H, Biloglav A, et al. . The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Nat Genet. 2015;47(6):672-676. PubMed

Olsson L, Castor A, Behrendtz M, et al. . Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. Leukemia. 2014;28(2):302-310. PubMed

Panagopoulos I, Gorunova L, Andersen HK, et al. . PAN3-PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia. Exp Hematol Oncol. 2018;7:7. PubMed PMC

Olsson L, Lundin-Ström KB, Castor A, et al. . Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases. Genes Chromosomes Cancer. 2018;57(11):604-607. PubMed

Duployez N, Abou Chahla W, Lejeune S, et al. . Detection of a new heterozygous germline ETV6 mutation in a case with hyperdiploid acute lymphoblastic leukemia. Eur J Haematol. 2018;100(1):104-107. PubMed

Zaliova M, Hovorkova L, Vaskova M, Hrusak O, Stary J, Zuna J. Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16. Genes Chromosomes Cancer. 2016;55(9):727-737. PubMed

Wang K, Li M, Hadley D, et al. . PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17(11):1665-1674. PubMed PMC

Rasmussen M, Sundström M, Göransson Kultima H, et al. . Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity. Genome Biol. 2011;12(10):R108. PubMed PMC

DePristo MA, Banks E, Poplin R, et al. . A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491-498. PubMed PMC

Thomas GWC, Wang RJ, Puri A, et al. . Reproductive longevity predicts mutation rates in primates. Curr Biol. 2018;28(19):3193-3197.e5. PubMed PMC

Cibulskis K, Lawrence MS, Carter SL, et al. . Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213-219. PubMed PMC

Chen X, Schulz-Trieglaff O, Shaw R, et al. . Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics. 2016;32(8):1220-1222. PubMed

Rausch T, Zichner T, Schlattl A, Stütz AM, Benes V, Korbel JO. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics. 2012;28(18):i333-i339. PubMed PMC

Wala JA, Bandopadhayay P, Greenwald NF, et al. . SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res. 2018;28(4):581-591. PubMed PMC

Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLOS Comput Biol. 2016;12(4):e1004873. PubMed PMC

Cingolani P, Platts A, Wang L, et al. . A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80-92. PubMed PMC

Kiyoi H, Naoe T, Nakano Y, et al. . Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood. 1999;93(9):3074-3080. PubMed

Lilljebjörn H, Henningsson R, Hyrenius-Wittsten A, et al. . Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun. 2016;7:11790. PubMed PMC

Dobin A, Davis CA, Schlesinger F, et al. . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15-21. PubMed PMC

van de Geijn B, McVicker G, Gilad Y, Pritchard JK. WASP: allele-specific software for robust molecular quantitative trait locus discovery. Nat Methods. 2015;12(11):1061-1063. PubMed PMC

Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323. PubMed PMC

McCarthy S, Das S, Kretzschmar W, et al. ; Haplotype Reference Consortium . A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48(10):1279-1283. PubMed PMC

Okuyama K, Strid T, Kuruvilla J, et al. . PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia. PLoS Genet. 2019;15(8):e1008280. PubMed PMC

Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754-1760. PubMed PMC

Ramírez F, Dündar F, Diehl S, Grüning BA, Manke T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 2014;42(Web Server issue):W187-W191. PubMed PMC

van Heeringen SJ, Veenstra GJ. GimmeMotifs: a de novo motif prediction pipeline for ChIP-sequencing experiments. Bioinformatics. 2011;27(2):270-271. PubMed PMC

Weirauch MT, Yang A, Albu M, et al. . Determination and inference of eukaryotic transcription factor sequence specificity. Cell. 2014;158(6):1431-1443. PubMed PMC

Heinz S, Benner C, Spann N, et al. . Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576-589. PubMed PMC

Fornes O, Castro-Mondragon JA, Khan A, et al. . JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48(D1):D87-D92. PubMed PMC

Durand NC, Shamim MS, Machol I, et al. . Juicer provides a one-click system for analyzing loop-resolution Hi-C experiments. Cell Syst. 2016;3(1):95-98. PubMed PMC

Wu HJ, Michor F. A computational strategy to adjust for copy number in tumor Hi-C data. Bioinformatics. 2016;32(24):3695-3701. PubMed PMC

Stansfield JC, Cresswell KG, Dozmorov MG. multiHiCcompare: joint normalization and comparative analysis of complex Hi-C experiments. Bioinformatics. 2019;35(17):2916-2923. PubMed PMC

Crane E, Bian Q, McCord RP, et al. . Condensin-driven remodelling of X chromosome topology during dosage compensation. Nature. 2015;523(7559):240-244. PubMed PMC

Wolf J, Passmore LA. mRNA deadenylation by Pan2-Pan3. Biochem Soc Trans. 2014;42(1):184-187. PubMed PMC

Weischenfeldt J, Dubash T, Drainas AP, et al. . Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nat Genet. 2017;49(1):65-74. PubMed PMC

Hnisz D, Weintraub AS, Day DS, et al. . Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science. 2016;351(6280):1454-1458. PubMed PMC

Ooi WF, Nargund AM, Lim KJ, et al. . Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma. Gut. 2020;69(6):1039-1052. PubMed

Stam RW, den Boer ML, Schneider P, et al. . Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia. Blood. 2005;106(7):2484-2490. PubMed

Ozeki K, Kiyoi H, Hirose Y, et al. . Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood. 2004;103(5):1901-1908. PubMed

Kang H, Wilson CS, Harvey RC, et al. . Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children’s Oncology Group study. Blood. 2012;119(8):1872-1881. PubMed PMC

Garza-Veloz I, Martinez-Fierro ML, Jaime-Perez JC, et al. . Identification of differentially expressed genes associated with prognosis of B acute lymphoblastic leukemia. Dis Markers. 2015;2015:828145. PubMed PMC

Kuchenbauer F, Kern W, Schoch C, et al. . Detailed analysis of FLT3 expression levels in acute myeloid leukemia. Haematologica. 2005;90(12):1617-1625. PubMed

Paulsson K, Horvat A, Strömbeck B, et al. . Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2008;47(1):26-33. PubMed

Li Y, Schwab C, Ryan S, et al. . Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature. 2014;508(7494):98-102. PubMed PMC

Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008;19(4):379-390. PubMed

Paulsson K, Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2009;48(8):637-660. PubMed